Form 4 for MRNA Moderna
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001127602-23-008449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-02 | 2023-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | +2,410 | 1.63M | +0.1% | $0 |
| D | 2023-03-02 | 2023-03-01 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $138.03 | -1,072 | 1.63M | -0.1% | -$148.0K |
| DM | 2023-03-02 | 2023-02-28 | MRNA | Hoge Stephen | Pres | A - Grant | $0.00 | +47.0K | 9,768 | New | $0 |
| D | 2023-03-02 | 2023-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -2,410 | 9,643 | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | M | A | 2,410 | $0.00 | 1,630,103 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 1,072 | $138.03 | 1,629,031 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-02-28 | A | A | 37,217 | $0.00 | 37,217 | D | $138.81 · 2024-02-28 to 2033-02-28 | 37,217 Common Stock | (F5) 25% of this option will vest and become exercisable on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 4 | Derivative | Restricted Stock Units | 2023-02-28 | A | A | 9,768 | $0.00 | 9,768 | D | $0.00 · — to — | 9,768 Common Stock | (F6) 25% of the shares subject to this restricted stock unit award will vest on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 5 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 2,410 | $0.00 | 9,643 | D | $0.00 · 2022-02-28 to — | 2,410 Common Stock | (F4) 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |